Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus

BACKGROUND: The relationship between cell-bound complement activation products (CB-CAPs: EC4d, EC3d), anti-C1q, soluble complement C3/C4 and disease activity in systemic lupus erythematosus (SLE) was evaluated. METHODS: Per protocol, at baseline all SLE subjects enrolled in this longitudinal study p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lupus Sci Med
Main Authors: Buyon, Jill, Furie, Richard, Putterman, Chaim, Ramsey-Goldman, Rosalind, Kalunian, Kenneth, Barken, Derren, Conklin, John, Dervieux, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Biomarker Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051407/
https://ncbi.nlm.nih.gov/pubmed/27752336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2016-000165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados